BibTeX
CSL-JSON
MLA
Harvard
Vildagliptin
release_md6uwly3cfel3ffeb4wg3dy3lm
by
Urspeter Masche
Abstract
Mit Vildagliptin steht - neben Sitagliptin - ein weiterer sogen. DPP-4-Hemmer zur Verfügung. Das Medikament senkt das HbA1c weniger stark als Metformin. Daten zu klinisch relevanten Endpunkten liegen noch keine vor.
In application/xml+jats format
Archived Files and Locations
application/pdf
174.7 kB
file_dl6jdhwwajd7lpjktsfi35uanq
|
www.infomed.ch (web) web.archive.org (webarchive) |
Read Archived PDF
Preserved and Accessible
Type
Stage
Date 2008-12-18
article-journalStage
published
Date 2008-12-18
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
access all versions, variants, and formats of this works (eg, pre-prints)
Cite This
Lookup Links
oaDOI/unpaywall (OA fulltext)
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar